Nan Li is a Managing Director at Obvious Ventures, a venture capital firm investing in entrepreneurs reimagining every sector of the global economy. Nan leads the firm’s investments in companies harnessing deep tech to transform legacy industries like pharmaceuticals, protein therapy, industrial materials, and manufacturing. His investments include Recursion Pharmaceuticals, LabGenius, DarwinAI, Octave Health, Zymergen, and Planet. Prior to joining Obvious, Nan managed early-stage tech investments for Eric Schmidt's Innovation Endeavors and led Product, Operations, and Finance at Gigwalk - a mobile crowdsourced data and analytics company funded by Greylock Partners and August Capital. Nan was also a VC at Bain Capital Ventures, a management consultant at Bain & Company, and a Product Manager at Microsoft. He is an adjunct at Stanford University, lecturing on Applied Symbolic Systems in Venture Capital & Entrepreneurship.
VC activity is booming in the healthcare sector. Point in case, investments have reached record-breaking numbers, including in the AI/ML field. This panel will discuss the future of the investment sector, how investments in AI/ML are shaping healthcare, and what to expect in the years to come.